Halozyme Therapeutics

NEW HAVEN, Conn., July 20, 2026 Biohaven Ltd. has announced that new Phase I clinical data for BHV-1530, its...

SAN DIEGO, July 20, 2026 Halozyme Therapeutics has entered into a global collaboration and license agreement with Incyte to...

SEATTLE, July 20, 2026 The Society of NeuroInterventional Surgery (SNIS) has unveiled a series of groundbreaking scientific presentations for...

FOSTER CITY, Calif., June 16, 2026 Gilead Sciences has announced that the U.S. Food and Drug Administration (FDA) has...

LEHI, Utah, June 15, 2026 Halia Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted...

SAN DIEGO, June 15, 2026 Halozyme Therapeutics, Inc. has confirmed that it expects zero to minimal impact on royalty...

SAN DIEGO and MENLO PARK, Calif., May 6, 2026 Halozyme Therapeutics and Oruka Therapeutics announced a global exclusive collaboration...